Active, not recruitingPhase 1NCT03651349

To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers

Studying Amyotrophic Lateral Sclerosis (ALS)

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Everfront Biotech Co., Ltd.
Intervention
HK-001(drug)
Enrollment
56 enrolled
Eligibility
20 years · All sexes
Timeline
20212026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03651349 on ClinicalTrials.gov

Other trials for Amyotrophic Lateral Sclerosis (ALS)

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic Lateral Sclerosis (ALS)

← Back to all trials